Tag: GCP non-compliance

Mapping Deviation Patterns to CAPA and Process Redesign Mapping Deviation Patterns to CAPA and Process Redesign In the realm of clinical research, adherence to the protocol and regulatory requirements is paramount. Deviation from these established guidelines can lead to significant challenges, necessitating a Comprehensive Corrective and Preventive Action (CAPA) plan to address these issues. This…

Read More “Mapping Deviation Patterns to CAPA and Process Redesign” »

Using Trending Data to Identify Systemic Deviation Drivers Using Trending Data to Identify Systemic Deviation Drivers Introduction to Systemic Deviation Drivers in Clinical Trials In the context of clinical trials, understanding and addressing protocol deviations is crucial for ensuring compliance with regulatory standards and maintaining the integrity of trial data. A protocol deviation refers to…

Read More “Using Trending Data to Identify Systemic Deviation Drivers” »

Cross-Functional Workshops to Design Fixes for Recurrent Deviations Protocol deviations represent a significant challenge in clinical trials, impacting trial integrity and regulatory compliance. As clinical operations, regulatory affairs, and medical affairs professionals, it is essential to establish effective cross-functional workshops to address the recurrent deviations and enhance compliance with good clinical practice (GCP). This tutorial…

Read More “Cross-Functional Workshops to Design Fixes for Recurrent Deviations” »

Documentation Deviations: Missing Signatures, Dates and Source Gaps Documentation Deviations: Missing Signatures, Dates and Source Gaps In the realms of clinical trial services, documentation integrity is paramount. Regulatory bodies such as the FDA, EMA, and MHRA stress the importance of maintaining comprehensive and accurate documents to ensure trials adhere to Good Clinical Practice (GCP). Regulatory…

Read More “Documentation Deviations: Missing Signatures, Dates and Source Gaps” »

DCT-Specific Deviation Patterns in Telehealth and Remote Assessments As the clinical research field increasingly embraces decentralized clinical trials (DCTs), understanding deviation patterns specific to telehealth and remote assessments becomes crucial. Protocol deviations can jeopardize the reliability and integrity of clinical trial results. This tutorial serves as a comprehensive guide to identifying common deviation patterns and…

Read More “DCT-Specific Deviation Patterns in Telehealth and Remote Assessments” »

Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up In the context of clinical trials, safety assessments are critical to ensuring patient well-being and the integrity of trial results. Deviations in these assessments can lead to significant ramifications for both the conduct of the study and…

Read More “Safety Assessment Deviations: Missed Vitals, Labs and AE Follow-Up” »

Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity Eligibility criteria are a fundamental component of clinical trial design, serving to define the population for which the study results will be applicable. However, deviations from these criteria can significantly impact subject inclusion and, ultimately,…

Read More “Eligibility Criteria Deviations: Impact on Subject Inclusion and Data Integrity” »

Informed Consent Deviations: Prevention, Detection and Remediation Informed Consent Deviations: Prevention, Detection and Remediation Understanding Informed Consent in Clinical Trials Informed consent is a fundamental aspect of conducting ethical and compliant clinical trials. It ensures that participants are fully aware of their rights, the nature of the trial, potential risks and benefits, and alternative treatments…

Read More “Informed Consent Deviations: Prevention, Detection and Remediation” »

IP Handling and Dosing Deviations: Controls That Really Work In clinical trials, handling investigational products (IPs) with precision is crucial. Among the various challenges faced, dosing deviations are common and can have significant implications on the integrity of clinical trial results, including those related to the adaura clinical trial. This tutorial aims to provide a…

Read More “IP Handling and Dosing Deviations: Controls That Really Work” »

Common Protocol Deviation Patterns in Clinical Trials—and How to Fix Them Common Protocol Deviation Patterns in Clinical Trials—and How to Fix Them Clinical trials are critical for advancing medical science and ensuring the efficacy and safety of new treatments. However, protocol deviations can jeopardize the integrity of clinical trial results, necessitating a robust understanding of…

Read More “Common Protocol Deviation Patterns in Clinical Trials—and How to Fix Them” »